Items where authors include "Schmid, P."

Article

Toribio‐Flórez, D. orcid.org/0000-0001-9706-709X, Altenmüller, M.S. orcid.org/0000-0002-1714-3601, Douglas, K.M. orcid.org/0000-0002-0381-6924 et al. (64 more authors) (2025) Victims of conspiracies? An examination of the relationship between conspiracy beliefs and dispositional individual victimhood. European Journal of Social Psychology. ISSN 0046-2772

Cologna, V. orcid.org/0000-0003-3706-8669, Mede, N.G. orcid.org/0000-0001-5707-7568, Berger, S. orcid.org/0000-0003-2392-1024 et al. (238 more authors) (2025) Trust in scientists and their role in society across 68 countries. Nature Human Behaviour, 9 (4). pp. 713-730. ISSN 2397-3374

Mede, N.G. orcid.org/0000-0001-5707-7568, Cologna, V., Berger, S. orcid.org/0000-0003-2392-1024 et al. (238 more authors) (2025) Perceptions of science, science communication, and climate change attitudes in 68 countries – the TISP dataset. Scientific Data, 12. 114. ISSN 2052-4463

Hanna, D., Merrick, S., Ghose, A. et al. (24 more authors) (2024) Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. British Journal of Cancer, 130 (12). pp. 1916-1920. ISSN 0007-0920

Oswald, A.J., Symeonides, S.N., Wheatley, D. et al. (16 more authors) (2023) Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study. Breast Cancer Research and Treatment, 199. pp. 35-46. ISSN 0167-6806

Wu, Y. orcid.org/0000-0003-4080-3935, Biswas, D. orcid.org/0000-0001-9141-5188, Usaite, I. et al. (302 more authors) (2022) A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer, 3. pp. 696-709. ISSN 2662-1347

Verrill, M., Wardley, A.M., Retzler, J. orcid.org/0000-0002-0008-3104 et al. (6 more authors) (2020) Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage. Health and Quality of Life Outcomes, 18. 353. ISSN 1477-7525

Schmid, P., Zaiss, M., Harper-Wynne, C. et al. (29 more authors) (2019) Fulvestrant plus vistusertib vs fulvestrant plus everolimus vs fulvestrant alone for women with hormone receptor–positive metastatic breast cancer: the MANTA phase 2 randomized clinical trial. JAMA Oncology, 5 (11). pp. 1556-1564. ISSN 2374-2445

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Meisenberg, C., Ward, S. E., Schmid, P. et al. (1 more author) (2014) TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan. Journal of Cancer Science and Therapy, 6 (7). pp. 258-267. ISSN 1948-5956

Eccles, S.A., Aboagye, E.O., Ali, S. et al. (84 more authors) (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Research, 15. R92. ISSN 1465-5411

Proceedings Paper

Cameron, D., Symeonides, S., Brunt, M. et al. (10 more authors) (2020) Abstract P3-11-09: ARISTACAT - Aromatase inhibition plus minus saracatinib as advanced breast cancer therapy: A randomised phase II study of aromatase inhibition plus/minus the Src-inhibitor AZD0530 in post-menopausal women with advanced breast cancer. In: Cancer Research. 2019 San Antonio Breast Cancer Symposium, 10-14 Dec 2019, San Antonio, Texas, USA. American Association for Cancer Research .